Pharmaceutical CXO Market, Global Outlook and Forecast 2023-2029

Report ID: MMG158144 | Category: Service & Software | Pages: 119 | Format: PDF | Published Date: August 01,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

CXO is a pharmaceutical contract outsourcing service, which mainly includes pharmaceutical contract research and development services (CRO) and pharmaceutical contract manufacturing services (CDMO) and CMO.
In the process of new drug development, through pharmaceutical contract outsourcing, pharmaceutical companies or biotechnology companies commission drug R&D and production companies to provide professional R&D services, including technical process development, API and CCMO production, formulation production, etc.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical CXO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical CXO. This report contains market size and forecasts of Pharmaceutical CXO in global, including the following market information:
Global Pharmaceutical CXO Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Pharmaceutical CXO market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
CRO Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Pharmaceutical CXO include WuXi AppTec, Tigermed, Charles River Laboratories, Pharmaron Inc, Labcorp Drug Development, Boehringer Ingelheim, GenScript, MabPlex International and Shanghai ChemPartner, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pharmaceutical CXO companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pharmaceutical CXO Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Pharmaceutical CXO Market Segment Percentages, by Type, 2022 (%)
    CRO
    CMO
    CDMO
Global Pharmaceutical CXO Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Pharmaceutical CXO Market Segment Percentages, by Application, 2022 (%)
    Pharmaceutical Companies
    Biotechnology Companies
Global Pharmaceutical CXO Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Pharmaceutical CXO Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pharmaceutical CXO revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Pharmaceutical CXO revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    WuXi AppTec
    Tigermed
    Charles River Laboratories
    Pharmaron Inc
    Labcorp Drug Development
    Boehringer Ingelheim
    GenScript
    MabPlex International
    Shanghai ChemPartner
    Wuxi Biologics
    Pharmablock
    Jiuzhou Pharma
    Asym Chemical
    IQVIA
    Syneos Health
    Parexel
    AGC Biologics
    FUJIFILM Diosynth Biotechnologies
    Patheon
    Catalent
    Lonza Group AG
    Avid Bioservices
    AbbVie
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pharmaceutical CXO, market overview.
Chapter 2: Global Pharmaceutical CXO market size in revenue.
Chapter 3: Detailed analysis of Pharmaceutical CXO company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pharmaceutical CXO in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Pharmaceutical CXO Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Pharmaceutical CXO Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Pharmaceutical CXO Overall Market Size
    2.1 Global Pharmaceutical CXO Market Size: 2022 VS 2029
    2.2 Global Pharmaceutical CXO Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Pharmaceutical CXO Players in Global Market
    3.2 Top Global Pharmaceutical CXO Companies Ranked by Revenue
    3.3 Global Pharmaceutical CXO Revenue by Companies
    3.4 Top 3 and Top 5 Pharmaceutical CXO Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Pharmaceutical CXO Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Pharmaceutical CXO Players in Global Market
        3.6.1 List of Global Tier 1 Pharmaceutical CXO Companies
        3.6.2 List of Global Tier 2 and Tier 3 Pharmaceutical CXO Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Pharmaceutical CXO Market Size Markets, 2022 & 2029
        4.1.2 CRO
        4.1.3 CMO
        4.1.4 CDMO
    4.2 By Type - Global Pharmaceutical CXO Revenue & Forecasts
        4.2.1 By Type - Global Pharmaceutical CXO Revenue, 2018-2023
        4.2.2 By Type - Global Pharmaceutical CXO Revenue, 2024-2029
        4.2.3 By Type - Global Pharmaceutical CXO Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Pharmaceutical CXO Market Size, 2022 & 2029
        5.1.2 Pharmaceutical Companies
        5.1.3 Biotechnology Companies
    5.2 By Application - Global Pharmaceutical CXO Revenue & Forecasts
        5.2.1 By Application - Global Pharmaceutical CXO Revenue, 2018-2023
        5.2.2 By Application - Global Pharmaceutical CXO Revenue, 2024-2029
        5.2.3 By Application - Global Pharmaceutical CXO Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Pharmaceutical CXO Market Size, 2022 & 2029
    6.2 By Region - Global Pharmaceutical CXO Revenue & Forecasts
        6.2.1 By Region - Global Pharmaceutical CXO Revenue, 2018-2023
        6.2.2 By Region - Global Pharmaceutical CXO Revenue, 2024-2029
        6.2.3 By Region - Global Pharmaceutical CXO Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Pharmaceutical CXO Revenue, 2018-2029
        6.3.2 US Pharmaceutical CXO Market Size, 2018-2029
        6.3.3 Canada Pharmaceutical CXO Market Size, 2018-2029
        6.3.4 Mexico Pharmaceutical CXO Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Pharmaceutical CXO Revenue, 2018-2029
        6.4.2 Germany Pharmaceutical CXO Market Size, 2018-2029
        6.4.3 France Pharmaceutical CXO Market Size, 2018-2029
        6.4.4 U.K. Pharmaceutical CXO Market Size, 2018-2029
        6.4.5 Italy Pharmaceutical CXO Market Size, 2018-2029
        6.4.6 Russia Pharmaceutical CXO Market Size, 2018-2029
        6.4.7 Nordic Countries Pharmaceutical CXO Market Size, 2018-2029
        6.4.8 Benelux Pharmaceutical CXO Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Pharmaceutical CXO Revenue, 2018-2029
        6.5.2 China Pharmaceutical CXO Market Size, 2018-2029
        6.5.3 Japan Pharmaceutical CXO Market Size, 2018-2029
        6.5.4 South Korea Pharmaceutical CXO Market Size, 2018-2029
        6.5.5 Southeast Asia Pharmaceutical CXO Market Size, 2018-2029
        6.5.6 India Pharmaceutical CXO Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Pharmaceutical CXO Revenue, 2018-2029
        6.6.2 Brazil Pharmaceutical CXO Market Size, 2018-2029
        6.6.3 Argentina Pharmaceutical CXO Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Pharmaceutical CXO Revenue, 2018-2029
        6.7.2 Turkey Pharmaceutical CXO Market Size, 2018-2029
        6.7.3 Israel Pharmaceutical CXO Market Size, 2018-2029
        6.7.4 Saudi Arabia Pharmaceutical CXO Market Size, 2018-2029
        6.7.5 UAE Pharmaceutical CXO Market Size, 2018-2029
7 Pharmaceutical CXO Companies Profiles
    7.1 WuXi AppTec
        7.1.1 WuXi AppTec Company Summary
        7.1.2 WuXi AppTec Business Overview
        7.1.3 WuXi AppTec Pharmaceutical CXO Major Product Offerings
        7.1.4 WuXi AppTec Pharmaceutical CXO Revenue in Global Market (2018-2023)
        7.1.5 WuXi AppTec Key News & Latest Developments
    7.2 Tigermed
        7.2.1 Tigermed Company Summary
        7.2.2 Tigermed Business Overview
        7.2.3 Tigermed Pharmaceutical CXO Major Product Offerings
        7.2.4 Tigermed Pharmaceutical CXO Revenue in Global Market (2018-2023)
        7.2.5 Tigermed Key News & Latest Developments
    7.3 Charles River Laboratories
        7.3.1 Charles River Laboratories Company Summary
        7.3.2 Charles River Laboratories Business Overview
        7.3.3 Charles River Laboratories Pharmaceutical CXO Major Product Offerings
        7.3.4 Charles River Laboratories Pharmaceutical CXO Revenue in Global Market (2018-2023)
        7.3.5 Charles River Laboratories Key News & Latest Developments
    7.4 Pharmaron Inc
        7.4.1 Pharmaron Inc Company Summary
        7.4.2 Pharmaron Inc Business Overview
        7.4.3 Pharmaron Inc Pharmaceutical CXO Major Product Offerings
        7.4.4 Pharmaron Inc Pharmaceutical CXO Revenue in Global Market (2018-2023)
        7.4.5 Pharmaron Inc Key News & Latest Developments
    7.5 Labcorp Drug Development
        7.5.1 Labcorp Drug Development Company Summary
        7.5.2 Labcorp Drug Development Business Overview
        7.5.3 Labcorp Drug Development Pharmaceutical CXO Major Product Offerings
        7.5.4 Labcorp Drug Development Pharmaceutical CXO Revenue in Global Market (2018-2023)
        7.5.5 Labcorp Drug Development Key News & Latest Developments
    7.6 Boehringer Ingelheim
        7.6.1 Boehringer Ingelheim Company Summary
        7.6.2 Boehringer Ingelheim Business Overview
        7.6.3 Boehringer Ingelheim Pharmaceutical CXO Major Product Offerings
        7.6.4 Boehringer Ingelheim Pharmaceutical CXO Revenue in Global Market (2018-2023)
        7.6.5 Boehringer Ingelheim Key News & Latest Developments
    7.7 GenScript
        7.7.1 GenScript Company Summary
        7.7.2 GenScript Business Overview
        7.7.3 GenScript Pharmaceutical CXO Major Product Offerings
        7.7.4 GenScript Pharmaceutical CXO Revenue in Global Market (2018-2023)
        7.7.5 GenScript Key News & Latest Developments
    7.8 MabPlex International
        7.8.1 MabPlex International Company Summary
        7.8.2 MabPlex International Business Overview
        7.8.3 MabPlex International Pharmaceutical CXO Major Product Offerings
        7.8.4 MabPlex International Pharmaceutical CXO Revenue in Global Market (2018-2023)
        7.8.5 MabPlex International Key News & Latest Developments
    7.9 Shanghai ChemPartner
        7.9.1 Shanghai ChemPartner Company Summary
        7.9.2 Shanghai ChemPartner Business Overview
        7.9.3 Shanghai ChemPartner Pharmaceutical CXO Major Product Offerings
        7.9.4 Shanghai ChemPartner Pharmaceutical CXO Revenue in Global Market (2018-2023)
        7.9.5 Shanghai ChemPartner Key News & Latest Developments
    7.10 Wuxi Biologics
        7.10.1 Wuxi Biologics Company Summary
        7.10.2 Wuxi Biologics Business Overview
        7.10.3 Wuxi Biologics Pharmaceutical CXO Major Product Offerings
        7.10.4 Wuxi Biologics Pharmaceutical CXO Revenue in Global Market (2018-2023)
        7.10.5 Wuxi Biologics Key News & Latest Developments
    7.11 Pharmablock
        7.11.1 Pharmablock Company Summary
        7.11.2 Pharmablock Business Overview
        7.11.3 Pharmablock Pharmaceutical CXO Major Product Offerings
        7.11.4 Pharmablock Pharmaceutical CXO Revenue in Global Market (2018-2023)
        7.11.5 Pharmablock Key News & Latest Developments
    7.12 Jiuzhou Pharma
        7.12.1 Jiuzhou Pharma Company Summary
        7.12.2 Jiuzhou Pharma Business Overview
        7.12.3 Jiuzhou Pharma Pharmaceutical CXO Major Product Offerings
        7.12.4 Jiuzhou Pharma Pharmaceutical CXO Revenue in Global Market (2018-2023)
        7.12.5 Jiuzhou Pharma Key News & Latest Developments
    7.13 Asym Chemical
        7.13.1 Asym Chemical Company Summary
        7.13.2 Asym Chemical Business Overview
        7.13.3 Asym Chemical Pharmaceutical CXO Major Product Offerings
        7.13.4 Asym Chemical Pharmaceutical CXO Revenue in Global Market (2018-2023)
        7.13.5 Asym Chemical Key News & Latest Developments
    7.14 IQVIA
        7.14.1 IQVIA Company Summary
        7.14.2 IQVIA Business Overview
        7.14.3 IQVIA Pharmaceutical CXO Major Product Offerings
        7.14.4 IQVIA Pharmaceutical CXO Revenue in Global Market (2018-2023)
        7.14.5 IQVIA Key News & Latest Developments
    7.15 Syneos Health
        7.15.1 Syneos Health Company Summary
        7.15.2 Syneos Health Business Overview
        7.15.3 Syneos Health Pharmaceutical CXO Major Product Offerings
        7.15.4 Syneos Health Pharmaceutical CXO Revenue in Global Market (2018-2023)
        7.15.5 Syneos Health Key News & Latest Developments
    7.16 Parexel
        7.16.1 Parexel Company Summary
        7.16.2 Parexel Business Overview
        7.16.3 Parexel Pharmaceutical CXO Major Product Offerings
        7.16.4 Parexel Pharmaceutical CXO Revenue in Global Market (2018-2023)
        7.16.5 Parexel Key News & Latest Developments
    7.17 AGC Biologics
        7.17.1 AGC Biologics Company Summary
        7.17.2 AGC Biologics Business Overview
        7.17.3 AGC Biologics Pharmaceutical CXO Major Product Offerings
        7.17.4 AGC Biologics Pharmaceutical CXO Revenue in Global Market (2018-2023)
        7.17.5 AGC Biologics Key News & Latest Developments
    7.18 FUJIFILM Diosynth Biotechnologies
        7.18.1 FUJIFILM Diosynth Biotechnologies Company Summary
        7.18.2 FUJIFILM Diosynth Biotechnologies Business Overview
        7.18.3 FUJIFILM Diosynth Biotechnologies Pharmaceutical CXO Major Product Offerings
        7.18.4 FUJIFILM Diosynth Biotechnologies Pharmaceutical CXO Revenue in Global Market (2018-2023)
        7.18.5 FUJIFILM Diosynth Biotechnologies Key News & Latest Developments
    7.19 Patheon
        7.19.1 Patheon Company Summary
        7.19.2 Patheon Business Overview
        7.19.3 Patheon Pharmaceutical CXO Major Product Offerings
        7.19.4 Patheon Pharmaceutical CXO Revenue in Global Market (2018-2023)
        7.19.5 Patheon Key News & Latest Developments
    7.20 Catalent
        7.20.1 Catalent Company Summary
        7.20.2 Catalent Business Overview
        7.20.3 Catalent Pharmaceutical CXO Major Product Offerings
        7.20.4 Catalent Pharmaceutical CXO Revenue in Global Market (2018-2023)
        7.20.5 Catalent Key News & Latest Developments
    7.21 Lonza Group AG
        7.21.1 Lonza Group AG Company Summary
        7.21.2 Lonza Group AG Business Overview
        7.21.3 Lonza Group AG Pharmaceutical CXO Major Product Offerings
        7.21.4 Lonza Group AG Pharmaceutical CXO Revenue in Global Market (2018-2023)
        7.21.5 Lonza Group AG Key News & Latest Developments
    7.22 Avid Bioservices
        7.22.1 Avid Bioservices Company Summary
        7.22.2 Avid Bioservices Business Overview
        7.22.3 Avid Bioservices Pharmaceutical CXO Major Product Offerings
        7.22.4 Avid Bioservices Pharmaceutical CXO Revenue in Global Market (2018-2023)
        7.22.5 Avid Bioservices Key News & Latest Developments
    7.23 AbbVie
        7.23.1 AbbVie Company Summary
        7.23.2 AbbVie Business Overview
        7.23.3 AbbVie Pharmaceutical CXO Major Product Offerings
        7.23.4 AbbVie Pharmaceutical CXO Revenue in Global Market (2018-2023)
        7.23.5 AbbVie Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Pharmaceutical CXO Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?